Abstract 12161: Dipeptidyl Peptidase IV Inhibitor Therapy Modifies Systolic Blood Pressure in High Blood Pressure Diabetic Patients: Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) 2 Trial
Hirofumi Soejima(Kumamoto Health Science University), Hisao Ogawa(Kumamoto University Hospital), Sadanori Okada(Hyogo Medical University), Masako Waki(Shizuoka City Hospital), Masafumi Nakayama(Kumamoto University), Yoshihiko Saito(National Archives and Records Administration), Seigo Sugiyama(Diabetes Care Center), Shiro Uemura(Nara Medical University Hospital), Takeshi Morimoto(Hyogo Medical University), Hideaki Jinnouchi(Kumamoto University Hospital), Mio Sakuma(Hyogo Medical University), Naofumi Doi(Nara Medical University), Masao Kanauchi(Nara Medical University)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k